# A Phase 1 Study to Evaluate Pharmacokinetics, Safety and Tolerability of ZL-1503 in Healthy Volunteers

> **NCT07658482** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Zai Lab (Shanghai) Co., Ltd.** · enrollment: 36 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ZL-1503
- **DRUG:** ZL-1503
- **DRUG:** ZL-1503

## Key facts

- **NCT ID:** NCT07658482
- **Lead sponsor:** Zai Lab (Shanghai) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-03
- **Primary completion:** 2027-02-06
- **Final completion:** 2027-11-10
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07658482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07658482, "A Phase 1 Study to Evaluate Pharmacokinetics, Safety and Tolerability of ZL-1503 in Healthy Volunteers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07658482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*